Chitosan functionalized PCL nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy

References

• Alshetaili AS. 2021. Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines. Saudi J Biol Sci. 28(9):5065–5073.
   PubMed Web of Science ®Google Scholar
• Badri W, Miladi K, Nazari QA, Fessi H, Elaissari A. 2017. Effect of process and formulation parameters on polycaprolactone nanoparticles prepared by solvent displacement. Colloids Surf A. 516:238–244.
   Google Scholar
• Bhattacharya S. 2021. Fabrication of poly(sarcosine), poly(ethylene glycol), and poly(lactic-co-glycolic acid) polymeric nanoparticles for cancer drug delivery. J Drug Deliv Sci Technol. 61:102194.
   Web of Science ®Google Scholar
• Bouchnita A, Volpert V, Koury MJ, Hellander A. 2020. A multiscale model to design therapeutic strategies that overcome drug resistance to tyrosine kinase inhibitors in multiple myeloma. Math Biosci. 319:108293.
   PubMed Web of Science ®Google Scholar
• Chakradhar T, Mondal S, Vanapalli GK. 2019. A new stability indicating RP-HPLC method for estimation of osimertinib mesylate. J Drug Deliv Ther. 9(2-s):391–395.
   Google Scholar
• Chary PS, Rajana N, Bhavana V, Singh PK, Srivastava S, Madan J, Singh SB, Mehra NK. 2022. Chapter 1-Nanotechnology: advanced drug-targeting concepts, fundamentals, and strategies. In: Neelesh Kumar Mehra, Saurabh Srivastava, Jitender Madan, Pankaj kumar Singh, editors. Multifunctional nanocarriers. p: 1-24, Amsterdam, ‎Netherlands: Elsevier.‎
   Google Scholar
• Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu Y-L, Paz-Ares L. 2017. Lung cancer: current therapies and new targeted treatments. Lancet. 389(10066):299–311.
   PubMed Web of Science ®Google Scholar
• Hu X, Chen S, Yin H, Wang Q, Duan Y, Jiang L, Zhao L. 2020. Chitooligosaccharides-modified PLGA nanoparticles enhance the antitumor efficacy of AZD9291 (osimertinib) by promoting apoptosis. Int J Biol Macromol. 162:262–272.
   PubMed Web of Science ®Google Scholar
• Huang W, Tsui CP, Tang CY, Gu L. 2018. Effects of compositional tailoring on drug delivery behaviours of silica xerogel/polymer core–shell composite nanoparticles. Sci Rep. 8(1):1–13.
   PubMedGoogle Scholar
• Hussain Z, Sahudin S. 2016. Preparation, characterisation and colloidal stability of chitosan-tripolyphosphate nanoparticles: optimisation of formulation and process parameters. Int J Pharm Pharm Sci. 8(3):297–308.
   Google Scholar
• Javadzadeh Y, Ahadi F, Davaran S, Mohammadi G, Sabzevari A, Adibkia K. 2010. Preparation and physicochemical characterization of naproxen–PLGA nanoparticles. Colloids Surf B Biointerfaces. 81(2):498–502.
   PubMed Web of Science ®Google Scholar
• Larsen JE, Minna JD. 2011. Molecular biology of lung cancer: clinical implications. Clin Chest Med. 32(4):703–740.
   PubMed Web of Science ®Google Scholar
• Madani F, Esnaashari SS, Mujokoro B, Dorkoosh F, Khosravani M, Adabi M. 2018. Investigation of effective parameters on size of paclitaxel loaded PLGA nanoparticles. Adv Pharm Bull. 8(1):77–84.
   PubMed Web of Science ®Google Scholar
• Nimesh S, Manchanda R, Kumar R, Saxena A, Chaudhary P, Yadav V, Mozumdar S, Chandra R. 2006. Preparation, characterization and in vitro drug release studies of novel polymeric nanoparticles. Int J Pharm. 323(1–2):146–152.
   PubMedGoogle Scholar
• Panyam J, Williams D, Dash A, Leslie‐Pelecky D, Labhasetwar V. 2004. Solid‐state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J Pharm Sci. 93(7):1804–1814.
   PubMed Web of Science ®Google Scholar
• Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, Zakowski MF, Kris MG, Varmus H. 2005. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med. 2(3):e73.
   PubMed Web of Science ®Google Scholar
• Pawar VK, Singh Y, Sharma K, Shrivastav A, Sharma A, Singh A, Meher JG, Singh P, Raval K, Kumar A, et al. 2019. Improved chemotherapy against breast cancer through immunotherapeutic activity of fucoidan decorated electrostatically assembled nanoparticles bearing doxorubicin. Int J Biol Macromol. 122:1100–1114.
   PubMed Web of Science ®Google Scholar
• Poon K, Castellino V, Cheng Y. 2007. 2—Polymeric hydrophilic polymers in targeted drug delivery. In: Prakash, editor. Artificial cells, cell engineering and therapy. Elsevier: Amsterdam, The Netherlands; p. 42–71.
   Google Scholar
• Qu N, Lee RJ, Sun Y, Cai G, Wang J, Wang M, Lu J, Meng Q, Teng L, Wang D, et al. 2016. Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer. Int J Nanomedicine. 11:3451–3459.
   PubMed Web of Science ®Google Scholar
• Raval M, Patel P, Airao V, Bhatt V, Sheth N. 2021. Novel silibinin loaded chitosan-coated PLGA/PCL nanoparticles based inhalation formulations with improved cytotoxicity and bioavailability for lung cancer. BioNanoScience. 11(1):67–83.
   Web of Science ®Google Scholar
• Sharma DS, Gulati M, Singh SK, Singh PK, Wadhwa S. 2022. In Micro and Nano Technologies, Chapter 15 - Role of novel drug delivery systems in overcoming the challenges associated with intraocular delivery of drugs: an overview. In: Neelesh Kumar Mehra, Saurabh Srivastava, Jitender Madan, Pankaj kumar Singh, editors. Multifunctional nanocarriers; Elsevier. Amsterdam, Netherlands. p. 401–418.
   Google Scholar
• Shigematsu H, Gazdar AF. 2006. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer. 118(2):257–262.
   PubMed Web of Science ®Google Scholar
• Singh P, Gupta A, Jaiswal A, Dube A, Mishra S, Chaurasia MK. 2011. Design and development of amphotericin B bearing polycaprolactone microparticles for macrophage targeting. J Biomed Nanotechnol. 7(1):50–51.
   PubMed Web of Science ®Google Scholar
• Singh PK, Khatri DK, Singh SB, Sriram Anitha, e2022.. Chapter 9-Nanotechnology impact and its future perspectives on COVID-19 therapy. In: Anitha Sriram, Rahul Kumar, Indrani Maji, Dharmendra Kumar Khatri, Shashi Bala Singh, Saurabh Srivastava, Pankaj Kumar Singh. editors. An update on SARS-CoV-2: damage-response framework, potential therapeutic avenues and the impact of nanotechnology on COVID-19 therapy. Vol. 1. Bussum, Netherlands: Bentham Science Publishers.
   Google Scholar
• Singh PK, Khatri DK, Singh SB, Sriram A, editors. 2022b. Immunotherapeutic approaches to combat COVID-19. In: An update on SARS-CoV-2: damage-response framework, potential therapeutic avenues and the impact of nanotechnology on COVID-19 therapy. Bentham Science Publishers.
   Google Scholar
• Singh PK, Pawar VK, Jaiswal AK, Singh Y, Srikanth CH, Chaurasia M, Bora HK, Raval K, Meher JG, Gayen JR, et al. 2017. Chitosan coated PluronicF127 micelles for effective delivery of amphotericin B in experimental visceral leishmaniasis. Int J Biol Macromol. 105(Pt 1):1220–1231.
   PubMedGoogle Scholar
• Singh PK, Sah P, Meher JG, Joshi S, Pawar VK, Raval K, Singh Y, Sharma K, Kumar A, Dube A, et al. 2016. Macrophage-targeted chitosan anchored PLGA nanoparticles bearing doxorubicin and amphotericin B against visceral leishmaniasis. RSC Adv. 6(75):71705–71718.
   Web of Science ®Google Scholar
• Skupin-Mrugalska P, Minko T. 2020. Development of liposomal vesicles for osimertinib delivery to EGFR mutation—positive lung cancer cells. Pharmaceutics. 12(10):939.
   PubMed Web of Science ®Google Scholar
• Srinivas P, Pragna S. 2012. Formulation and evaluation of moxifloxacin hydrochloride ocular nanoparticles. Int J Nanodimens. 3(2):105–113.
   Google Scholar
• Sriram A, Tangirala S, Atmakuri S, Hoque S, Modani S, Srivastava S, Mahajan S, Maji I, Kumar R, Khatri D, et al. 2021. Budding multi-matrix technology—a retrospective approach, deep insights, and future perspectives. AAPS PharmSciTech. 22(8):1–40.
   Web of Science ®Google Scholar
• Vijayaraj S, Anitha S, Omshanthi B, Kumar KS. 2014. Synthesis and characterization of novel oxime prodrug of gliclizide. Asian J Chem. 26(20):6989–6992.
   Google Scholar
• Vijayaraj S, Omshanthi B, Anitha S, Sampath Kumar K. 2014. Synthesis and characterization of novel sulphoxide prodrug of famotidine. Indian J Pharm Educ Res. 48(4):35–44.
   Web of Science ®Google Scholar
• Wang R-T, Zhi X-Y, Yao S-Y, Zhang Y. 2015. LFC131 peptide-conjugated polymeric nanoparticles for the effective delivery of docetaxel in CXCR4 overexpressed lung cancer cells. Colloids Surf B Biointerfaces. 133:43–50.
   PubMed Web of Science ®Google Scholar
• Wheatley-Price P, Shepherd FA. 2008. Epidermal growth factor receptor inhibitors in the treatment of lung cancer: reality and hopes. Curr Opin Oncol. 20(2):162–175.
   PubMed Web of Science ®Google Scholar
• Zaharoff DA, Rogers CJ, Hance KW, Schlom J, Greiner JW. 2007. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine. 25(11):2085–2094.
   PubMed Web of Science ®Google Scholar